-
Pfizer's new migraine drug has been approved for market launch. Lilly and Novartis Same Target Injection have been approved successively
Today (January 26th), Pfizer announced that its new generation of specific migraine treatment drug, Rimezepam orally disintegrating tablets, has been approved by the National Medical Products Adminis ... -
Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
On January 26th, Pfizer announced that its new generation of specific migraine treatment drug, Rimezepam orally disintegrating tablets, has been approved by the National Medical Products Administrati ... -
Pfizer's new generation of specific migraine treatment drug, Loctite, has been approved in China
Pfizer announced on January 26th that its new generation of specific migraine treatment drug, Letaike (Rimezepam orally disintegrating tablets), has been approved by the National Medical Products Adm ... -
Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
According to AI News, on January 26th, Pfizer Pharmaceuticals announced on its official WeChat account that the new generation of specific migraine treatment drug, Rimezepam orally disintegrating tab ... -
Lilly Pharmaceuticals and Kanezumab Injection Approved for Preventive Treatment of Adult Migraine in China
On January 10th, Lilly Pharmaceuticals announced that Encore&Co; Reg; Jiakanezumab Injection has officially been approved by the National Medical Products Administration for the preventive treatment ... -
Lilly Plus Kanezumab Injection Approved in China for Preventive Treatment of Adult Migraine
On January 10th, Lilly Pharmaceuticals announced that Encore&Co; Reg; Jiakanezumab Injection has officially been approved by the National Medical Products Administration for the preventive treatment ... -
Pfizer Nose Spray Migraine Medicine Makes Its First Show at the Expo, Expected to Landing in Boao, Hainan early next year
Ruimei Jipan orally disintegrating tablets have been launched in the pilot area of Boao Lecheng and the Greater Bay Area of Guangdong, Hong Kong, and Macao, and have now benefited hundreds of migrain ...